Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-May-24 4:00 PM View:  | Aklog Lishan Chief Executive Officer Director | Lucid Diagnostics Inc. (LUCD) | 07-May-24 | Grant | 400,000 | -- | -- | 52% 766.63K to 1.17M | |
| 08-May-24 4:01 PM View: | McGrath Dennis M Chief Financial Officer | Lucid Diagnostics Inc. (LUCD) | 07-May-24 | Grant | 400,000 | -- | -- | 62% 643.57K to 1.04M | |
| 08-May-24 4:01 PM View: | O'Neil Shaun President and COO | Lucid Diagnostics Inc. (LUCD) | 07-May-24 | Grant | 400,000 | -- | -- | 316% 126.76K to 526.76K | |
| 08-May-24 4:01 PM View: | Gordon Michael Adam General Counsel and Secretary | Lucid Diagnostics Inc. (LUCD) | 07-May-24 | Grant | 400,000 | -- | -- | 100% 0 to 400.0K | |
| 20-Feb-24 4:49 PM View: | Pavmed Inc. 10% Owner | Lucid Diagnostics Inc. (LUCD) | 15-Feb-24 | Disposition (other) | 3,331,750 | -- | -- | (10%) 34.63M to 31.3M | |
| 30-Jan-24 5:29 PM View: | Pavmed Inc. 10% Owner | Lucid Diagnostics Inc. (LUCD) | 26-Jan-24 | Acquisition (other) | 3,331,770 | $1.40 | $4,675,470.00 | 11% 31.3M to 34.63M | |
| 27-Sep-23 8:53 PM View: | Lapidus Stanley Director | Lucid Diagnostics Inc. (LUCD) | 26-Sep-23 | Sale (Planned) | 29,747 | $1.45 | $43,173.10 | (23%) 131.34K to 101.59K | |
| 27-Sep-23 8:53 PM View: | Lapidus Stanley Director | Lucid Diagnostics Inc. (LUCD) | 25-Sep-23 | Sale (Planned) | 200 | $1.43 | $286.00 | (< 1%) 131.54K to 131.34K | |
| 22-Sep-23 6:39 PM View: | Lapidus Stanley Director | Lucid Diagnostics Inc. (LUCD) | 21-Sep-23 | Sale | 100 | $1.44 | $144.00 | (< 1%) 131.64K to 131.54K | |
| 22-Sep-23 6:39 PM View: | Lapidus Stanley Director | Lucid Diagnostics Inc. (LUCD) | 20-Sep-23 | Sale | 3,817 | $1.45 | $5,530.53 | (3%) 135.46K to 131.64K | |
| 02-Dec-22 6:08 PM View: | Pavmed Inc. 10% Owner | Lucid Diagnostics Inc. (LUCD) | 30-Nov-22 | Acquisition (other) | 3,375,230 | $1.92 | $6,474,460.00 | 9% 39.11M to 42.48M | |
| 22-Sep-22 11:46 AM View: | Lapidus Stanley Director | Lucid Diagnostics Inc. (LUCD) | 20-Sep-22 | Sale | 33,864 | $1.70 | $57,682.70 | (20%) 169.32K to 135.46K | |
| 10-Jan-22 8:07 PM View: | McGrath Dennis M Chief Financial Officer | Lucid Diagnostics Inc. (LUCD) | 07-Jan-22 | Grant | 60,000 | -- | -- | 11% 564.4K to 624.4K | |
| 10-Jan-22 8:06 PM View: | Aklog Lishan Chief Executive Officer Director | Lucid Diagnostics Inc. (LUCD) | 07-Jan-22 | Grant | 60,000 | -- | -- | 11% 564.4K to 624.4K | |
| 20-Oct-21 5:05 PM View: | Sparks Ronald M Director | Lucid Diagnostics Inc. (LUCD) | 18-Oct-21 | Grant | 84,660 | -- | -- | 100% 0 to 84.66K | |
| 20-Oct-21 5:04 PM View: | Pavmed Inc. 10% Owner | Lucid Diagnostics Inc. (LUCD) | 18-Oct-21 | Purchase | 571,428 | $14.00 | $7,999,990.00 | 2% 27.36M to 27.93M |
